Fifth Lane Capital’s Terns Pharmaceuticals TERN Stock Holding History

Fifth Lane Capital’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,000	Closed	-$422K	–	44
2026 Q1	$422K	Buy	+8,000	New	+$329K	0.51%	30

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fifth Lane Capital's TERN Position: Q2 2026 in Review

Fifth Lane Capital sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 8,000 shares — an estimated $422K sold.

Fifth Lane Capital first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $422K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Fifth Lane Capital reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Fifth Lane Capital sold 8,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $422K.
Fifth Lane Capital first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Fifth Lane Capital's Terns Pharmaceuticals position peaked at $422K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Fifth Lane Capital's 13F filing for Q2 2026, filed 6 Aug 2026.